Wen Cai

822 total citations
55 papers, 565 citations indexed

About

Wen Cai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Wen Cai has authored 55 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Epidemiology. Recurrent topics in Wen Cai's work include Renal cell carcinoma treatment (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Renal and related cancers (5 papers). Wen Cai is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Renal and related cancers (5 papers). Wen Cai collaborates with scholars based in China, United States and United Kingdom. Wen Cai's co-authors include Weiting Ge, Hanguang Hu, Wei Xue, Lixin Zhou, Baijun Dong, Hua Yao, Jiwei Huang, Yong Huang, Yonghui Chen and Yinuo Tan and has published in prestigious journals such as PLoS ONE, Cancer Research and Brain Research.

In The Last Decade

Wen Cai

50 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Cai China 16 262 209 179 122 106 55 565
Ayşe Ocak Duran Türkiye 11 197 0.8× 119 0.6× 82 0.5× 82 0.7× 65 0.6× 44 439
Yao Liang China 15 330 1.3× 282 1.3× 105 0.6× 144 1.2× 174 1.6× 40 703
Kae Kawachi Japan 14 186 0.7× 120 0.6× 105 0.6× 99 0.8× 66 0.6× 48 542
Ketki Tendulkar United States 13 345 1.3× 265 1.3× 76 0.4× 167 1.4× 42 0.4× 22 645
Jianhua Wang China 12 176 0.7× 86 0.4× 181 1.0× 83 0.7× 57 0.5× 42 589
H. Raith Germany 11 207 0.8× 137 0.7× 186 1.0× 233 1.9× 131 1.2× 16 732
Ji Hae Nahm South Korea 16 178 0.7× 172 0.8× 149 0.8× 196 1.6× 184 1.7× 52 785
Edem Agamah United States 12 176 0.7× 149 0.7× 87 0.5× 151 1.2× 119 1.1× 16 560
Ömer Yerci Türkiye 16 281 1.1× 168 0.8× 282 1.6× 208 1.7× 125 1.2× 76 891
M. L. Maestro Spain 13 171 0.7× 85 0.4× 92 0.5× 123 1.0× 61 0.6× 27 459

Countries citing papers authored by Wen Cai

Since Specialization
Citations

This map shows the geographic impact of Wen Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Cai more than expected).

Fields of papers citing papers by Wen Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Cai. The network helps show where Wen Cai may publish in the future.

Co-authorship network of co-authors of Wen Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Cai. A scholar is included among the top collaborators of Wen Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Cai. Wen Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chen, Yaoyao Zhong, Senlin Xu, et al.. (2025). TRIM24 promotes T-cell lymphoma development and glucocorticoid resistance via FUS-mediated phase separation of the glucocorticoid receptor. Drug Resistance Updates. 82. 101270–101270.
2.
Cui, Juanjuan, et al.. (2024). Decreased monocytic HLA-DR in patients with sepsis: Prediction of diagnosis, severity and prognosis. Clinical Biochemistry. 135. 110851–110851. 2 indexed citations
4.
Cui, Juanjuan, et al.. (2024). Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis. BMC Infectious Diseases. 24(1). 399–399. 2 indexed citations
6.
Tan, Dan, et al.. (2022). Intentional replantation combined root resection therapy for the treatment of type III radicular groove with two roots: A case report. World Journal of Clinical Cases. 10(20). 6991–6998. 5 indexed citations
7.
Cai, Wen, et al.. (2020). N6-methyladenosine (m6A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules. Journal of International Medical Research. 48(9). 1220750957–1220750957. 23 indexed citations
8.
Li, Ning, et al.. (2020). Tumor-Infiltrating Lymphocyte-Based Risk Score for Predicting Prognosis in Gastric Cancer. Frontiers in Oncology. 10. 522015–522015. 8 indexed citations
10.
Cai, Wen, et al.. (2019). Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis. Lipids in Health and Disease. 18(1). 14–14. 18 indexed citations
11.
Liu, Yi, et al.. (2018). Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China. Medicine. 97(9). e0021–e0021. 9 indexed citations
12.
Cai, Wen, Jin Zhang, Yonghui Chen, et al.. (2017). Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma. Chinese Journal of Cancer. 36(1). 47–47. 7 indexed citations
13.
Cai, Wen, Hai Zhong, Wen Kong, et al.. (2017). Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy. International Urology and Nephrology. 49(11). 1955–1963. 21 indexed citations
14.
Cai, Wen, Wen Kong, Baijun Dong, et al.. (2017). Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy. Clinical Genitourinary Cancer. 15(3). e437–e446. 30 indexed citations
15.
Fan, Liancheng, Xiao Wang, Chenfei Chi, et al.. (2017). Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(12). 1233–1241. 35 indexed citations
16.
Zhang, Yuexin, Wen Cai, Lei Miao, et al.. (2014). Association between the PNPLA3 I148M Polymorphism and Non-Alcoholic Fatty Liver Disease in the Uygur and Han Ethnic Groups of Northwestern China. PLoS ONE. 9(10). e108381–e108381. 20 indexed citations
17.
He, Huimei, Pingjie Huang, Dibo Hou, et al.. (2012). An Intelligent Signal Processing Method for High Speed Weighing System. International Journal of Food Engineering. 8(4). 1 indexed citations
18.
Cai, Wen, et al.. (2012). The associaion of serum uric acid level with prevalence of non-alcoholic fatty liver in Uyghur and Han ethnicities. Zhonghua neifenmi daixie zazhi. 28(11). 890–894. 1 indexed citations
19.
Cai, Wen. (1999). ANALYSIS OF THE FEATURES OF DOPAMINE RECEPTOR EXPRESSION ON ASTROCYTES. 1 indexed citations
20.
Cai, Wen. (1993). STUDIES ON THE TAXONOMY OF THE GENUS TRICHODERMA IN SOUTHWESTERN CHINA. Mycosystema. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026